Literature DB >> 6604605

Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies.

T A Poulton, N A Mooney, L J Nineham, F C Hay.   

Abstract

Immune complexes from patients with ovarian and endometrial cancer have been examined using the C1q solid phase (C1qSP) and polyethylene glycol (PEG) precipitation assays. The amount of IgG in the PEG precipitates was inversely correlated with the amount of IgM whilst the IgM values correlated positively with the C1qSP assay values. Separation studies revealed that most of the C1qSP activity was not precipitated from cancer sera by 2% PEG. The immune complexes were fractionated on Sephacryl S-300. Both the PEG precipitation and C1qSP assays detected high molecular weight immune complex like activity (greater than 19S). The C1qSP assay also detected a second peak of activity at approximately 7-8S. Most of the PEG detectable immune complexes from sera dissociated during column chromatography, whereas the C1qSP detectable complexes were relatively stable. Furthermore the IgG from fractionated PEG precipitates emerged as a monomer (7S) component. The PEG assay appeared to be detecting a high molecular weight complex containing mostly IgG rather than IgM with a low affinity for C1q, which was easily dissociated. The C1qSP assay detected a more stable high molecular weight complex containing a relatively high proportion of IgM and a low molecular weight complex, both with a high affinity for C1q.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6604605      PMCID: PMC1535663     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  The nature of immune complexes in human cancer sera.

Authors:  A N Theofilopoulos; B S Andrews; M M Urist; D L Morton; F J Dixon
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

2.  Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding tests.

Authors:  R D Rossen; R H Zubler; N K Day; M A Reisberg; A C Morgan; J U Gutterman; E M Hersh
Journal:  J Lab Clin Med       Date:  1978-02

3.  Circulating immune complexes in sera of patients with Burkett's lymphoma and nasopharyngeal carcinoma.

Authors:  R Heimer; G Klein
Journal:  Int J Cancer       Date:  1976-09-15       Impact factor: 7.396

4.  Immune complexes in ovarian cancer.

Authors:  P J McLaughlin; M R Price; R W Baldwin; D Vasey; E M Symonds
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

5.  Immune complexes in ovarian cancer.

Authors:  T A Poulton; M E Crowther; F C Hay; L J Nineham
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

6.  The Raji cell radioimmune assay for detecting immune complexes in human sera.

Authors:  A N Theofilopoulos; C B Wilson; F J Dixon
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

7.  Circulating immune complexes detected by 125I-Clq deviation test in sera of cancer patients.

Authors:  H Teshima; H Wanebo; C Pinsky; N K Day
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

8.  Immunoglobulin complexes in sera of patients with malignancy.

Authors:  E A Samayoa; F C McDuffie; A M Nelson; V L Go; H S Luthra; H W Brumfield
Journal:  Int J Cancer       Date:  1977-01       Impact factor: 7.396

9.  Circulating immune complexes in disseminated gonorrheal infection.

Authors:  L C Walker; T D Ahlin; K S Tung; R C Williams
Journal:  Ann Intern Med       Date:  1978-07       Impact factor: 25.391

10.  Clinical relevance of circulating immune complexes in human leukemia. Association in acute leukemia of the presence of immune complexes with unfavorable prognosis.

Authors:  N A Carpentier; G T Lange; D M Fiere; G J Fournie; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

View more
  2 in total

1.  When is a malaria immune complex not an immune complex?

Authors:  R J Pleass
Journal:  Parasite Immunol       Date:  2009-02       Impact factor: 2.280

2.  Clinical importance of circulating immune complexes in human acute lymphoblastic leukemia.

Authors:  M V Croce; M Fejes; N Riera; D A Minoldo; A Segal-Eiras
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.